Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 2
1990 1
1991 1
1992 1
1993 4
1994 2
1995 2
1996 1
2002 1
2003 1
2004 1
2005 1
2006 1
2007 1
2009 1
2010 1
2011 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).
Adelstein DJ, Moon J, Hanna E, Giri PG, Mills GM, Wolf GT, Urba SG. Adelstein DJ, et al. Head Neck. 2010 Feb;32(2):221-8. doi: 10.1002/hed.21179. Head Neck. 2010. PMID: 19557750 Free PMC article. Clinical Trial.
VM-26 in gastric cancer. A Southwest Oncology Group study.
Berenberg JL, Tangen C, Macdonald JS, Barlogie B, Laufman LR. Berenberg JL, et al. Invest New Drugs. 1993 Nov;11(4):333-4. doi: 10.1007/BF00874433. Invest New Drugs. 1993. PMID: 8157475 Clinical Trial.
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.
Alberts DS, Green S, Hannigan EV, O'Toole R, Stock-Novack D, Anderson P, Surwit EA, Malvlya VK, Nahhas WA, Jolles CJ. Alberts DS, et al. J Clin Oncol. 1992 May;10(5):706-17. doi: 10.1200/JCO.1992.10.5.706. J Clin Oncol. 1992. PMID: 1569443 Clinical Trial.
Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials.
Albain KS, Green SR, Lichter AS, Hutchins LF, Wood WC, Henderson IC, Ingle JN, O'Sullivan J, Osborne CK, Martino S. Albain KS, et al. J Clin Oncol. 1996 Nov;14(11):3009-17. doi: 10.1200/JCO.1996.14.11.3009. J Clin Oncol. 1996. PMID: 8918499
25 results